- Home
- Maintaining Fertility During Testosterone Replacement Therapy
Maintaining Fertility During Testosterone Therapy
Introduction
Welcome to this discussion about preserving fertility while undergoing testosterone replacement therapy (TRT). Low testosterone affects many men, including younger ones, and we’ll explore why levels are declining, the impact on fertility, and evidence-based treatment options. This article aims to provide clear, actionable insights to help you make informed decisions about hormone health without compromising future family plans.

At MD Total Wellness in Brea, CA, we focus on personalized men’s health solutions, including hormone optimization that prioritizes fertility. Our team offers free consultations and in-office testosterone testing to tailor a plan that fits your life and goals.
The Rising Challenge of Low Testosterone in Younger Men
Low testosterone, or hypogonadism, is increasingly common, even among men in their 20s and 30s. Symptoms like fatigue, reduced libido, mood changes, and muscle loss can significantly impact quality of life. Published studies clearly show that average testosterone levels in men have declined substantially over the past 50 years, with several analyses revealing a drop of about 1% per year since the 1980s! This generational decline affects younger generations, where environmental factors like obesity, plastics exposure, sedentary lifestyles, and stress may contribute. As a result, more young men are seeking treatment, but traditional TRT can pose challenges for those planning to start or expand families.
For men who want to preserve fertility, several options exist beyond standard TRT. These range from monotherapy alternatives to combined regimens that maintain sperm production. Baseline fertility testing and periodic retesting is recommended to monitor progress and adjust as needed. Consulting a specialist ensures a balanced approach, as untreated low testosterone can also impact fertility.
Exploring Treatment Options to Preserve Fertility
When fertility is a priority, choosing the right treatment is important. Standard TRT alone suppresses natural testosterone production via the hypothalamic-pituitary-gonadal axis, reducing luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which leads to decreased sperm production and potential infertility. However, options vary in their impact, effectiveness, and suitability based on age and deficiency severity.
Testosterone Replacement Therapy Alone
TRT monotherapy, typically injections, effectively raises serum testosterone but impairs fertility by halting spermatogenesis in most men, often leading to oligospermia or azoospermia. While this is typically reversible, recovery timelines vary. A comprehensive review of studies indicates that about 67% of men regain normal sperm counts within 6 months after stopping TRT, 90% by 12 months, and nearly 100% by 24 months. Factors like age, TRT duration, and baseline health influence this; older men or those on long-term therapy may take longer. Although permanent infertility is rare and not extensively documented, the topic lacks large-scale, long-term studies, so some uncertainty remains—recovery might not always reach pre-treatment levels, especially with prolonged use. For family planning, experts advise stopping TRT 3-6 months before attempting conception, with supportive therapies like HCG to speed recovery if needed. Baseline semen analysis before starting can provide a reference point.
Clomiphene or Enclomiphene Monotherapy
Selective estrogen receptor modulators (SERMs) like clomiphene citrate (Clomid) or its isomer enclomiphene offer fertility-preserving alternatives by blocking estrogen feedback in the brain, boosting LH and FSH to stimulate natural testosterone production. These are particularly effective for younger men with mild secondary hypogonadism, where the testes remain responsive. Studies show clomiphene increases testosterone by 100-200% while maintaining or improving sperm parameters, making it useful for fertility-conscious patients. Enclomiphene, with fewer estrogenic side effects, similarly elevates testosterone and preserves spermatogenesis, often preferred for its safety profile. However, efficacy diminishes in older men (over 40-50) or those with primary hypogonadism, where testicular function is impaired—response rates drop, and symptoms may persist. Side effects include headaches, visual changes (more with clomiphene), or mood swings, but they’re generally well-tolerated orally.
Enclomiphene Combined with Testosterone Therapy
Combining enclomiphene with TRT aims to harness TRT’s symptom relief while using the SERM to counteract fertility suppression. This approach can work by maintaining some LH/FSH signaling, potentially preserving sperm production better than TRT alone. However, results are inconsistent; not all men respond, as TRT’s strong suppression may override enclomiphene’s effects. Limited studies suggest it boosts testosterone further and supports fertility in select cases, but monitoring is essential—baseline and follow-up semen analyses can gauge effectiveness.
HCG Combined with Testosterone Therapy
Human chorionic gonadotropin (HCG) with TRT may be the most reliable option for maintaining fertility, as HCG mimics LH to directly stimulate testicular testosterone and sperm production. Low doses (250-500 IU twice or thrice weekly) have been shown in studies to preserve spermatogenesis during TRT, preventing azoospermia and maintaining normal sperm counts in most men. For example, a trial using 500 IU every other day kept intra-testicular testosterone high and sperm parameters stable. HCG’s direct action on Leydig cells makes it more consistent than SERMs, especially for older men or severe cases. Anecdotal reports highlight additional benefits from HCG like improved mood, energy, and libido independent of serum testosterone, possibly from localized effects or brain receptor activation. Risks include elevated estrogen (managed with aromatase inhibitors) or injection discomfort, but it’s generally safe. Baseline and periodic fertility testing (every 6-12 months) ensure ongoing efficacy, with adjustments as needed.
Personalized Fertility-Preserving Care at MD Total Wellness
At MD Total Wellness, we specialize in personalized men’s hormone therapy, recognizing that one-size-fits-all approaches fall short, especially for fertility concerns. Our in-office lab allows for convenient, free testosterone testing during consultations, providing immediate insights to guide your plan. We emphasize personalized regimens, such as TRT combined with HCG and regular semen analyses to monitor and maintain fertility while optimizing energy, mood, and vitality.
Beyond hormones, we offer peptide therapy for recovery and performance, GLP-1 receptor agonists for weight management, advanced hair restoration, and sexual wellness treatments. Whether you’re a young professional delaying family or managing age-related decline, our evidence-based approach ensures safe, effective results tailored to your lifestyle.
If you have symptoms of low testosterone, such as low energy, low sex drive, ED, or loss of muscle mass, schedule a free consultation and in-office testosterone test at MD Total Wellness today.
References
- 1. Travison TG, Araujo AB, O'Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007;92(1):196-202.
- 2. Lokeshwar SD, Patel P, Fantus RJ, et al. Decline in Serum Testosterone Levels Among Adolescent and Young Adult Men in the USA. Eur Urol Focus. 2021;7(4):886-889.
- 3. Patel AS, Leong JY, Ramasamy R. Prediction of male infertility by the World Health Organization laboratory manual for assessment of semen analysis: A systematic review. Arab J Urol. 2018;16(1):96-102.
- 4. Kohn TP, Louis MR, Pickett SM, et al. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertil Steril. 2017;107(2):351-357.
- 5. Samplaski MK, Loai Y, Wong K, Lo KC, Grober ED, Jarvi KA. Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters. Fertil Steril. 2014;101(1):64-69.
- 6. Krzastek SC, Smith RP. Non-testosterone management of male hypogonadism: an examination of the existing literature. Transl Androl Urol. 2020;9(Suppl 2):S160-S170.
- 7. Ribeiro MA, Gameiro LF, Scarano WR, Briton-Jones C. Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in male infertility patients: a short-course randomized study. BJU Int. 2018;122(5):889-897.
- 8. Earl JA, Kim ED. Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism. Expert Rev Endocrinol Metab. 2019;14(3):157-165.
- 9. Shoshany O, Abhyankar N, Mufarreh N, Daniel G, Niederberger C. Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men. Fertil Steril. 2016;105(3):589-594.
- 10. Da Ros CT, Averbeck MA. Twenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency - a prospective study. Int Braz J Urol. 2012;38(4):512-518.
- 11. Alphahormones. Enclomiphene with TRT. Alphahormones Blog. 2023. https://alphahormones.com/enclomiphene-with-trt/enclomiphene-with-trt
- 12. Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595-2602.
- 13. Modernaestheticsmd. HCG for Men: Boost Testosterone, Energy & Vitality. Modernaestheticsmd Blog. 2025. https://modernaestheticsmd.com/med-spa-blog/hcg-for-men-boost-testosterone-energy-vitality
Schedule Your Consultation
Work with our board-certified clinicians to build a personalized care plan.